Concepedia

Engineered oncolytic bacteria HCS1 exerts high immune stimulation and safety profiles for cancer therapy

Yujie Sun, Yanxia Guo, Xiaoqing Liu, Jinling Liu, Honglai Sun, Zhongying Li, Min Wen, Shengnan Jiang, Wenzhi Tan, Jin Zheng

Theranostics · 2023 · 21 citations · 44 references

DOIFull text

Open access

Concepts

Abstract

HCS1 strain manifests high prospects for cancer therapeutics and is a promising option for future clinical cancer immunotherapy.

References

44

Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti–PD-L1 efficacy

Ayelet Sivan, Leticia Corrales, Nathaniel Hubert et al. · Science · 2015 · 3.8K citations · Full text

, , +17

The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893.

WILLIAM B. COLEY · PubMed · 1991 · 975 citations

, , +5

Phase I Study of the Intravenous Administration of Attenuated<i>Salmonella typhimurium</i>to Patients With Metastatic Melanoma

John Toso, Vee J. Gill, Patrick Hwu et al. · Journal of Clinical Oncology · 2002 · 712 citations

, , +13

Programmable bacteria induce durable tumor regression and systemic antitumor immunity

Sreyan Chowdhury, Samuel Castro, Courtney Coker et al. · Nature Medicine · 2019 · 674 citations

, , +17

Analysis of Cell Viability by the Lactate Dehydrogenase Assay

Priti Kumar, Arvindhan Nagarajan, Pradeep D. Uchil · Cold Spring Harbor Protocols · 2018 · 664 citations

, , +15